Steve Orndorff is a serial entrepreneur with more than 25 years experience in the biotechnology industry. Previously he was President and CEO of Univera Pharmaceuticals, Inc., a drug discovery company focused on diseases of inflammation and the immune response. During his career he has had responsibility in a broad array of disciplines such as basic research, manufacturing, product development and business development at various biotechnology companies including Genex Corporation, NutraSweet, Inc., and ZeaGen, Inc. Dr. Orndorff is a past President of the Society for Industrial Microbiology and a founding Board member of the Colorado BioScience Association. He received a B.S. in Biology from Virginia Tech and a Ph.D. in microbiology from University of Maryland.